Symbio Pharmaceuticals Limited's total assets for Q2 2025 were ¥4.14B, a decrease of -11.32% from the previous quarter. JP:4582 total liabilities were ¥1.78B for the fiscal quarter, a 39.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.